Hims & Hers Expands North American Footprint with Canadian Market Entry

The telehealth provider Hims & Hers officially launched operations in Canada on December 4, 2025. This strategic move was executed through the acquisition of Livewell, a domestic digital health platform. The expansion grants the company access to a substantial new market where approximately two-thirds of the adult population is classified as overweight or living with obesity. The timing is considered strategic, aligning with the anticipated 2026 approval of generic semaglutid in Canada.

This Canadian foray follows a familiar playbook, mirroring the company’s earlier UK expansion via the takeover of Zava. By leveraging Livewell’s established local infrastructure, Hims & Hers can navigate regulatory frameworks efficiently and begin serving customers immediately. The geographic diversification Read more...